Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
17.9%
% of HRTS's 39 holdings also in OZEM
30.4%
% of OZEM's 23 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 6.4% | 14.2% | 6.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.9% | 4.7% | 3.9% |
|
AMGEN INC | 5.1% | 3.2% | 3.2% |
|
REGENERON PHARMACEUTICALS | 2.4% | 2.3% | 2.3% |
 |
ZEALAND PHARMA A/S | 1.3% | 4.7% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to OZEM
|
VERTEX PHARMACEUTICALS INC | 5.7% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% |
|
CRINETICS PHARMACEUTICALS INC | 3.8% |
|
BRIDGEBIO PHARMA, INC. | 3.8% |
|
NOVO NORDISK A/S-B | 3.6% |
|
CYTOKINETICS INC | 3.3% |
 |
ASTRAZENECA PLC | 3.1% |
|
BOSTON SCIENTIFIC CORP | 3.1% |
|
ASCENDIS PHARMA A/S | 3.1% |
 |
MEDTRONIC PLC | 3.0% |
HRTS Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -16.9% |
|
ELI LILLY & CO | -7.8% |
 |
ROCHE HOLDING LTD | -4.9% |
|
ALTIMMUNE, INC. | -4.6% |
|
ASTRAZENECA PLC-SPONS ADR | -3.9% |
|
ZEALAND PHARMA A/S | -3.5% |
 |
INNOVENT BIOLOGICS, INC. | -3.2% |
|
PFIZER INC | -3.0% |
|
SCHOLAR ROCK HOLDING CORP. | -2.7% |
 |
HANMI PHARM CO LTD | -2.5% |